SEC Filing Summary for Adicet Bio, Inc.

This filing details a Form 4 document for Adicet Bio, Inc. (ACET) reporting ownership changes by Michael Grissinger, who is a director at the company. On June 21, 2026, Grissinger acquired 4,200 stock options with a purchase price of $0.00 per share. These options, exercisable into 4,200 shares of Common Stock, have an exercise price of $8.10 and expire on June 20, 2036. The options vest in full on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders, provided Grissinger continues his service on the board. Following this transaction, Grissinger directly owns 4,200 shares.